Barceló Rico, Fátima; Bondía Company, Jorge; Diez Ruano, José Luís; Rossetti ., Paolo(Mary Ann Liebert, 2012)
[EN] Background: Continuous glucose monitoring (CGM) devices estimate plasma glucose (PG) from measurements in compartments alternative to blood. The accuracy of currently available CGM is yet unsatisfactory and may depend ...
Barceló-Rico, Fátima; Diez, José-Luís; Rossetti, Paolo; Vehi, Josep; Bondía Company, Jorge(Institute of Electrical and Electronics Engineers, 2013)
[EN] Minimally or noninvasive continuous glucose monitors estimate plasma glucose from compartments alternative to blood, and may revolutionize the management of diabetes. However, the accuracy of current devices is still ...
Ampudia-Blasco, Javier; Rossetti ., Paolo; Ascaso, Juan F.(Mary Ann Liebert, 2011)
[EN] Type 2 diabetes is characterized by insulin resistance and progressive b-cell deterioration. As b-cell function
declines, most patients with type 2 diabetes treated with oral agents, in monotherapy or combination, ...
[EN] Background: Postprandial (PP) control remains a challenge for closed-loop (CL) systems. Few studies with inconsistent results have systematically investigated the PP period.
Objective: To compare a new CL algorithm ...
[EN] Since the early 2000s, there has been an exponentially increasing development of new diabetes-applied technology such as continuous glucose monitoring, bolus calculators, and "smart" pumps, with the expectation of ...
Moscardó García, Vanessa(Universitat Politècnica de València, 2019-05-13)
[ES] Las personas con diabetes tipo 1 carecen de la capacidad de secretar insulina y, por lo tanto, necesitan regular su glucosa en sangre con la administración de insulina exógena. El páncreas artificial se presenta como ...
[EN] OBJECTIVE-To assess the role of adiposity on the pharmacodynamics of basal insulins NPH, detemir, and glargine in type 2 diabetes mellitus (T2DM), as estimated by glucose infusion rate (GIR) and endogenous glucose ...
[EN] Continuous glucose monitors (CGM) have improved the management of patients with type 1 diabetes (T1D), with glucose oxidase (GOx)-based sensors being the most used. However, they are potentially subject to both ...
[EN] Introduction Meal composition is known to affect glycemic variability and glucose control in type 1 diabetes. The objective of this work was to evaluate the effect of high carbohydrate meals of different nutritional ...
[EN] Background:
Closed-loop (CL) systems aims to outperform usual treatments in blood glucose control and continuous glucose monitors (CGM) are a key component in such systems. Meals represents one of the main disturbances ...
Laguna Sanz, Alejandro José(Universitat Politècnica de València, 2011-12-19)
Several glucoregulatory models are studies and a new model is proposed. Experiments are developed following an optimal design methodology. The designed experiments are applied in home monitoring of diabetic patients.
OBJECTIVE-To compare the pharmacokinetics and pharmacodynamics of NPH, glargine, and detemir insulins in type 2 diabetic subjects.
RESEARCH DESIGN AND METHODS-This study used a single-blind, three-way, cross-over design. ...
Moscardo-Garcia, Vanessa; Bondía Company, Jorge; Ampudia-Blasco, Francisco Javier; Fanelli, Carmine G; Lucidi, Paola; Rossetti, Paolo(Mary Ann Liebert, 2018-03)
[EN] Background: Continuous glucose monitoring (CGM) accuracy during hypoglycemia is suboptimal. This might be partly explained by insulin or hypoglycemia-induced changes in the plasma interstitial subcutaneous (SC) fluid ...
Continuous glucose monitors can measure interstitial glucose concentration in real time for closed-loop glucose control systems, known as artificial pancreas. These control systems use an insulin feedback to maintain plasma ...
Revert Tomás, Ana; Garelli, Fabricio; Picó, Jesús; De Battista, Hernan; Rossetti, Paolo; Bondía Company, Jorge(Institute of Electrical and Electronics Engineers, 2013-08)
[EN] The artificial pancreas aims at the automatic deliv-ery of insulin for glycemic control in patients with type 1 diabetes, i.e., closed-loop glucose control. One of the challenges of the arti-ficial pancreas is to avoid ...
Laguna Sanz, Alejandro José(Editorial Universitat Politècnica de València, 2014-04-30)
Postprandial characterization of patients with type 1 diabetes is crucial for the development of an automatic glucose control system (Artificial Pancreas). Uncertainty sources within the patient, and variability of the ...